Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Mohamed E. Salem
Sort by
Journal Article
Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer
Jonathan D Sorah and others
The Oncologist, Volume 27, Issue 12, December 2022, Pages 1006–e930, https://doi.org/10.1093/oncolo/oyac222
Published: 26 October 2022
Journal Article
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer
Mohamed E. Salem and others
The Oncologist, Volume 26, Issue 10, October 2021, Pages e1730–e1741, https://doi.org/10.1002/onco.13908
Published: 05 August 2021
Journal Article
Molecular Analyses of Left‐ and Right‐Sided Tumors in Adolescents and Young Adults with Colorectal Cancer
Mohamed E. Salem and others
The Oncologist, Volume 25, Issue 5, May 2020, Pages 404–413, https://doi.org/10.1634/theoncologist.2019-0552
Published: 17 December 2019
Journal Article
Impact of Patient Age on Molecular Alterations of Left‐Sided Colorectal Tumors
Alberto Puccini and others
The Oncologist, Volume 24, Issue 3, March 2019, Pages 319–326, https://doi.org/10.1634/theoncologist.2018-0117
Published: 17 July 2018
Journal Article
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma
Mohamed E. Salem and others
The Oncologist, Volume 23, Issue 11, November 2018, Pages 1319–1327, https://doi.org/10.1634/theoncologist.2018-0143
Published: 04 June 2018
Journal Article
Immuno‐Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD‐L1 Testing May Not Be Enough
Benjamin A. Weinberg and others
The Oncologist, Volume 23, Issue 10, October 2018, Pages 1171–1177, https://doi.org/10.1634/theoncologist.2018-0034
Published: 27 April 2018
Advertisement
Advertisement